Geode Capital Management
GTBP icon

Geode Capital Management’s GT Biopharma GTBP Stock Holding History

Geode Capital Management’s Portfolio GTBP Stock Details GTBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$131K Sell
266,788
-27,671
-9% -$11.2K ﹤0.01% 4040
2026
Q1 		$120K Buy
294,459
+275,201
+1,429% +$150K ﹤0.01% 4086
2025
Q4 		$15.1K Sell
19,258
-4,708
-20% -$3.34K ﹤0.01% 4409
2025
Q3 		$14.3K Buy
23,966
+129
+0.5% +$193 ﹤0.01% 4438
2025
Q2 		$85.4K Buy
23,837
+751
+3% +$1.94K ﹤0.01% 4104
2025
Q1 		$51.7K Buy
23,086
+8,187
+55% +$19.3K ﹤0.01% 4193
2024
Q4 		$45.5K Sell
14,899
-142
-0.9% -$384 ﹤0.01% 4257
2024
Q3 		$34.5K Buy
15,041
+3,857
+34% +$9.21K ﹤0.01% 4332
2024
Q2 		$31.7K Hold
11,184
– – ﹤0.01% 4377
2024
Q1 		$49.8K Sell
11,184
-60
-0.5% -$317 ﹤0.01% 4322
2023
Q4 		$86K Hold
11,244
– – ﹤0.01% 4227
2023
Q3 		$81.4K Buy
11,244
+3,796
+51% +$31.4K ﹤0.01% 4311
2023
Q2 		$69.7K Hold
7,448
– – ﹤0.01% 4439
2023
Q1 		$123K Hold
7,448
– – ﹤0.01% 4261
2022
Q4 		$199K Sell
7,448
-16
-0.2% -$799 ﹤0.01% 4107
2022
Q3 		$394K Sell
7,464
-1,446
-16% -$111K ﹤0.01% 3852
2022
Q2 		$799K Sell
8,910
-3,170
-26% -$240K ﹤0.01% 3523
2022
Q1 		$1.04M Sell
12,080
-852
-7% -$75.2K ﹤0.01% 3599
2021
Q4 		$1.18M Sell
12,932
-1,211
-9% -$181K ﹤0.01% 3633
2021
Q3 		$2.86M Buy
14,143
+2,589
+22% +$779K ﹤0.01% 3205
2021
Q2 		$5.37M Buy
11,554
+7,208
+166% +$3M ﹤0.01% 2853
2021
Q1 		$891K Buy
+4,346
New +$759K ﹤0.01% 3604

Other funds holding GTBP

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
OWA
Opal Wealth Advisors Jericho, New York $463M AUM 20.47% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
4WM
49 Wealth Management Austin, Texas $524M AUM 16.59% 1-Year Est. Return
A
Alongside Austin, Texas $525M AUM
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return

Geode Capital Management's GTBP Position: Q2 2026 in Review

Geode Capital Management reduced its GT Biopharma (GTBP) stake by 9.4% in Q2 2026, selling an estimated $11.2K and leaving 266,788 shares worth $131K. The position accounts for ﹤0.01% of the portfolio, ranked #4040.

Geode Capital Management first reported a position in GTBP in Q1 2021 and has held it in 22 quarters since. The position peaked at $5.37M in Q2 2021. 59 funds tracked by Wall St. Rank hold GTBP as of Q2 2026.

  • Geode Capital Management held 266,788 shares of GT Biopharma worth $131K as of Q2 2026.
  • Geode Capital Management sold 27,671 GT Biopharma shares in Q2 2026, an estimated $11.2K.
  • GT Biopharma made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #4040 holding.
  • Geode Capital Management first reported a position in GT Biopharma in Q1 2021 and has held it in 22 quarters since.
  • Geode Capital Management's GT Biopharma position peaked at $5.37M in Q2 2021.
  • 59 funds tracked by Wall St. Rank held GT Biopharma as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.